Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.8M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$131M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| MCENANY PATRICK J | Nov 12, 2024 | Sell | 192,000 | $23.201 | $4.5M |
| MCENANY PATRICK J | Nov 12, 2024 | Sell | 70,000 | $23.421 | $1.6M |
| MCENANY PATRICK J | Nov 11, 2024 | Sell | 230,000 | $23.548 | $5.4M |
| Tierney David S | Aug 21, 2024 | Sell | 15,000 | $20.097 | $300,000 |
| Miller Steve | Aug 20, 2024 | Sell | 50,000 | $20.585 | $1M |
| INGENITO GARY | Aug 9, 2024 | Sell | 100,000 | $18.04 | $1.8M |
| Del Carmen Jeffrey | Aug 9, 2024 | Sell | 30,000 | $18.42 | $550,000 |
| Del Carmen Jeffrey | Aug 9, 2024 | Sell | 6,058 | $18.44 | $110,000 |
| Del Carmen Jeffrey | Jun 7, 2024 | Sell | 7,541 | $16.07 | $120,000 |
| INGENITO GARY | Jun 5, 2024 | Sell | 80,000 | $16.16 | $1.3M |
| Daly Richard J | Jun 4, 2024 | Sell | 17,323 | $15.975 | $280,000 |
| Harper Molly | Jun 3, 2024 | Sell | 5,333 | $16.304 | $87,000 |
| Tierney David S | Apr 8, 2024 | Sell | 25,000 | $15.68 | $390,000 |
| Elsbernd Brian | Mar 27, 2024 | Sell | 25,000 | $16.44 | $410,000 |
| Harper Molly | Dec 15, 2023 | Sell | 10,000 | $14.37 | $140,000 |
| Harper Molly | Dec 15, 2023 | Sell | 4,000 | $14.43 | $58,000 |
| Tierney David S | Dec 12, 2023 | Sell | 50,000 | $13.325 | $670,000 |
| GRANDE ALICIA | Dec 11, 2023 | Sell | 30,000 | $13.786 | $410,000 |
| GRANDE ALICIA | Dec 8, 2023 | Sell | 20,000 | $14.3 | $290,000 |
| INGENITO GARY | Dec 6, 2023 | Sell | 50,000 | $14.02 | $700,000 |
| Miller Steve | Dec 5, 2023 | Sell | 40,000 | $14.24 | $570,000 |
| MCENANY PATRICK J | May 15, 2023 | Sell | 26,151 | $13.23 | $350,000 |
| Tierney David S | Apr 5, 2023 | Sell | 30,000 | $16.83 | $500,000 |
| Del Carmen Jeffrey | Mar 29, 2023 | Sell | 20,983 | $16.7 | $350,000 |
| Del Carmen Jeffrey | Mar 29, 2023 | Sell | 19,017 | $16.69 | $320,000 |
| GRANDE ALICIA | Mar 29, 2023 | Sell | 20,000 | $16.7 | $330,000 |
| GRANDE ALICIA | Mar 29, 2023 | Sell | 10,000 | $16.67 | $170,000 |
| GRANDE ALICIA | Mar 28, 2023 | Sell | 28,216 | $16.6 | $470,000 |
| GRANDE ALICIA | Mar 22, 2023 | Sell | 38,524 | $16.51 | $640,000 |
| GRANDE ALICIA | Mar 22, 2023 | Sell | 3,260 | $16.41 | $53,000 |
| Elsbernd Brian | Mar 20, 2023 | Sell | 50,000 | $16.069 | $800,000 |
| INGENITO GARY | Dec 6, 2022 | Sell | 5,918 | $16.85 | $100,000 |
| Miller Steve | Nov 23, 2022 | Sell | 20,000 | $17.337 | $350,000 |
| COELHO PHILIP H | Nov 23, 2022 | Sell | 9,999 | $17.45 | $170,000 |
| GRANDE ALICIA | Nov 22, 2022 | Sell | 120,000 | $16.527 | $2M |
| COELHO PHILIP H | Nov 22, 2022 | Sell | 20,001 | $17.304 | $350,000 |
What's the latest insider transaction for Catalyst Pharmaceuticals?
The most recent insider transaction for Catalyst Pharmaceuticals was conducted by MCENANY PATRICK J, who sold 192,000 shares on November 12, 2024 at a price of $23.20 per share.
Which insider has sold the most CPRX stock over the last two years?
MCENANY PATRICK J has sold the most CPRX stock in the last 2 years, with a total value of $12M.
What is the total value of insider transactions for Catalyst Pharmaceuticals (CPRX) in the last 2 years?
The total value of insider transactions for Catalyst Pharmaceuticals in the last 2 years is negative, amounting to -$28M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Catalyst Pharmaceuticals' market confidence?
Over the last 2 years, insider transactions for Catalyst Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
